What are the recent advancements in reducing Anthracycline toxicity?
Recent advancements focus on improving the therapeutic index of anthracyclines. Strategies include developing nanoparticle formulations to enhance tumor targeting and reduce systemic exposure, and exploring combination therapies with agents that protect normal tissues. Research into alternative dosing strategies and new anthracycline derivatives also aims to reduce toxicity.
